71 related articles for article (PubMed ID: 1651428)
1. [Intracellular Ca2+ mobilization and its regulation in platelet activation].
Matsuno K; Koyama M
Rinsho Ketsueki; 1991 May; 32(5):467-74. PubMed ID: 1651428
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
[TBL] [Abstract][Full Text] [Related]
4. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
5. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
6. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
7. Efflux of cyclic GMP from activated human platelets.
Wu XB; Brüne B; Von Appen F; Ullrich V
Mol Pharmacol; 1993 Apr; 43(4):564-8. PubMed ID: 8386309
[TBL] [Abstract][Full Text] [Related]
8. [The studies on the mechanism of platelet activation induced by exogenous arachidonic acid with special reference to intraplatelet Ca2+ mobilization].
Koyama M
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):1044-56. PubMed ID: 7959585
[TBL] [Abstract][Full Text] [Related]
9. Na+/H+ exchange in PAF-stimulated platelets.
Borin ML; Pinelis VG; Azizova OA; Kudinov YV; Markov CM; Cragoe EJ; Khodorov BI
J Lipid Mediat; 1989; 1(5):257-72. PubMed ID: 2562435
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent phosphorylation of vasodilator-stimulated protein in platelets during coronary passage.
Pohl U; Nolte C; Bunse A; Eigenthaler M; Walter U
Am J Physiol; 1994 Feb; 266(2 Pt 2):H606-12. PubMed ID: 8141362
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
Manns JM; Brenna KJ; Colman RW; Sheth SB
Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet arachidonic acid liberation by endothelium-derived relaxing factor (EDRF) as studied with sin-1, a nitric oxide generating drug. Evidence for calcium-dependent and calcium-independent mechanisms.
Gassama-Diagne A; Simon MF; Chap H
J Lipid Mediat; 1992 Feb; 5(1):61-75. PubMed ID: 1327266
[TBL] [Abstract][Full Text] [Related]
13. Epinephrine induces intracellular Ca2+ mobilization in thrombin-desensitized platelets: a role for GPIb-IX-V.
Ghilotti M; Lova P; Balduini C; Torti M
Platelets; 2007 Mar; 18(2):135-42. PubMed ID: 17365862
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C.
Durante W; Kroll MH; Vanhoutte PM; Schafer AI
Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423
[TBL] [Abstract][Full Text] [Related]
16. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
Alheid U; Reichwehr I; Förstermann U
Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
[TBL] [Abstract][Full Text] [Related]
17. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed.
Pohl U; Busse R
Circ Res; 1989 Dec; 65(6):1798-803. PubMed ID: 2555082
[TBL] [Abstract][Full Text] [Related]
18. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors.
Geiger J; Nolte C; Walter U
Am J Physiol; 1994 Jul; 267(1 Pt 1):C236-44. PubMed ID: 8048483
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets.
Nakashima S; Tohmatsu T; Hattori H; Okano Y; Nozawa Y
Biochem Biophys Res Commun; 1986 Mar; 135(3):1099-104. PubMed ID: 3008741
[TBL] [Abstract][Full Text] [Related]
20. Influence of endothelin on human platelet aggregation and prostacyclin generation from human vascular endothelial cells in culture.
Kato K; Sawada S; Toyoda T; Kobayashi K; Shirai K; Yamamoto K; Tamagaki T; Yamagami M; Yoneda M; Takada O
Jpn Circ J; 1992 May; 56(5):422-31. PubMed ID: 1318427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
